Sustained Correction of a Murine Model of Phenylketonuria following a Single Intravenous Administration of AAVHSC15-PAH
Phenylketonuria is an inborn error of metabolism caused by loss of function of the liver-expressed enzyme phenylalanine hydroxylase and is characterized by elevated systemic phenylalanine levels that are neurotoxic. Current therapies do not address the underlying genetic disease or restore the natur...
Main Authors: | Seemin S. Ahmed, Hillard Rubin, Minglun Wang, Deiby Faulkner, Arnold Sengooba, Serena N. Dollive, Nancy Avila, Jeff L. Ellsworth, Diana Lamppu, Maria Lobikin, Jason Lotterhand, Laura Adamson-Small, Teresa Wright, Albert Seymour, Omar L. Francone |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050120300395 |
Similar Items
-
Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15.
by: Huei-Mei Chen, et al.
Published: (2020-01-01) -
Clade F AAVHSCs cross the blood brain barrier and transduce the central nervous system in addition to peripheral tissues following intravenous administration in nonhuman primates.
by: Jeff L Ellsworth, et al.
Published: (2019-01-01) -
Identification of a Novel Mutation in the PAH Gene in an Iranian Phenylketonuria Family: A Case Report
by: Masoumeh RAZIPOUR, et al.
Published: (2017-04-01) -
Spectrum of PAH gene variants among a population of Han Chinese patients with phenylketonuria from northern China
by: Ning Liu, et al.
Published: (2017-10-01) -
Population and evolutionary genetics of the PAH locus to uncover overdominance and adaptive mechanisms in phenylketonuria: Results from a multiethnic study
by: Abderrahim Oussalah, et al.
Published: (2020-01-01)